Research programme: H5N1 avian influenza virus vaccine - PowderMedAlternative Names: H5N1 avian influenza virus vaccine research programme - PowderMed
Latest Information Update: 04 Aug 2009
At a glance
- Originator PowderMed
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 04 Aug 2009 No development reported - Preclinical for Influenza virus infections in United Kingdom (Intradermal)
- 01 Sep 2005 Preclinical trials in Influenza virus infections in United Kingdom (Intradermal)